SPATA2L

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, SPATA2L mutation is significantly associated with the RNA expression of many other genes, with 1,331 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible SPATA2L-associated genes across cancer lineages are RNA5SP173, MIR610, and OR1L6. Each is linked with SPATA2L in more than 1 cancer types. Because this analysis shows association rather than direction, both SPATA2L-to-partner and partner-to-SPATA2L results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA5SP173 grouped by SPATA2L-low versus SPATA2L-high in BLCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SPATA2L→partner) and Y-score (partner→SPATA2L) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLCARNA5SP173 →+0.258+7.640<.001.00932
UCECMIR610 →+0.180+2.787.005.00332
CESCOR1L6 →+0.047+4.812<.001.00631
CESCLINC00314 →+0.058+4.669<.001.00731
CESCOR51A9P →+0.077+5.060<.001.00131
CESCOR6B2 →+0.060+4.409<.001.00631
Each partner links to its Q-omics profile. Showing the 6 strongest of 1,331 associations by consensus.

RNA5SP173 by SPATA2L expression — BLCA

Box plot of RNA5SP173 in SPATA2L-low vs SPATA2L-high samples in BLCA.

Explore this box plot interactively →

Exploration